This is the parent of Fresenius Medical, which operates dialysis clinics. The parent company also owns hospitals and a project management business. The dividend has been growing about 12% per year for about 15 years. (Analysts’ price target is €77.36)
Fresenius SE is a OTC stock, trading under the symbol FRE-GR on the Frankfurt Stock Exchange (FRE-GY). It is usually referred to as XETR:FRE or FRE-GR
In the last year, there was no coverage of Fresenius SE published on Stockchase.
Fresenius SE was recommended as a Top Pick by on . Read the latest stock experts ratings for Fresenius SE .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Fresenius SE published on Stockchase.
On 2024-04-24, Fresenius SE (FRE-GR) stock closed at a price of $27.32.